Viewing Study NCT02868905



Ignite Creation Date: 2024-05-06 @ 8:57 AM
Last Modification Date: 2024-10-26 @ 12:08 PM
Study NCT ID: NCT02868905
Status: UNKNOWN
Last Update Posted: 2016-08-16
First Post: 2016-08-11

Brief Title: Identification of Epigenetic Markers Common to Obesity and Alzheimers Disease in Women
Sponsor: Central Hospital Nancy France
Organization: Central Hospital Nancy France

Study Overview

Official Title: Identification of Epigenetic Markers Common to Obesity and Alzheimers Disease in Women - Pilot Study
Status: UNKNOWN
Status Verified Date: 2016-08
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Oba
Brief Summary: The purpose of this study is to compare average methylation of epigenetic markers on genomic DNA and some genes APP BACE LRP SorL1 involved in cerebral amyloid homeostasis

Of obese young adults and healthy young adults
Of obese young adults and individuals affected by Alzheimers disease AD having been obese at young adult age 50 years old or individuals affected by Alzheimers disease AD having never been obese

The secondary purpose is to determine if there is an association between the frequency of these epigenetic markers and elements associated to the metabolic syndrome lipidic and glycemic analysis leptinemia inflammation markers and clinical ones visceral fat mass body mass index in young adults
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None